IRWD Latest Headlines

Ironwood Sets Ambitious 2026 Guidance for LINZESS Net Sales and Profits—Adjusted EBITDA Projected to More Than Double

Market Chameleon (Mon, 5-Jan 10:36 AM)

Stock Market Today: S&P 500, Nasdaq, WTI Crude Futures Advance After US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus (UPDATED)

at www.benzinga.com (Mon, 5-Jan 8:36 AM)

Stock Market Today: S&P 500, Nasdaq Futures Rise, WTI Fluctuates Following US Strike On Venezuela— GH Research, Vertiv Holdings, Nukkleus In Focus

at www.benzinga.com (Mon, 5-Jan 5:21 AM)

Ironwood Pharmaceuticals Sharpens 2026 Guidance With Expected Surge in LINZESS Sales and EBITDA—What’s Powering This Confidence?

Market Chameleon (Fri, 2-Jan 9:53 AM)

Ironwood Targets Over $1.1 Billion in LINZESS Sales for 2026 Amid Strong Cash Position and R&D Progress

Market Chameleon (Fri, 2-Jan 7:59 AM)

Ironwood Lifts Full-Year Outlook as LINZESS Drives Record Q3 Profit and Cash Flow

Market Chameleon (Tue, 11-Nov 11:18 AM)

LINZESS Net Sales Jump 40% and FDA Approves Pediatric Use: Ironwood Pharmaceuticals Ups Guidance After Standout Q3

Market Chameleon (Mon, 10-Nov 10:33 AM)